Merav Bassan - Oct 29, 2023 Form 4 Insider Report for BiomX Inc. (PHGE)

Role: Chief Development Officer
Signature: /s/ Merav Bassan
Stock symbol: PHGE
Transactions as of: Oct 29, 2023
Transactions value $: $0
Form type: 4
Date filed: 10/31/2023, 05:13 PM
Previous filing: Mar 3, 2023
Next filing: Dec 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHGE	Common Stock Options - Right to Buy	Disposed to Issuer	$0	-190K	-100%	$0.00^*	0	Oct 29, 2023	Common Stock	0	$10.00	Direct	F1
transaction	PHGE	Common Stock Options - Right to Buy	Award	$0	+190K		$0.00^*	0	Oct 29, 2023	Common Stock	0	$0.28	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/10/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 10/10/2020, and the remainder vesting in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.

Content

The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/10/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 10/10/2020, and the remainder vesting in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.